Evidence map›Paper›PMID 24008231›Full record

ReviewEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2013

Development and application of MLVA methods as a tool for inter-laboratory surveillance.

C A Nadon, E Trees, L K Ng, E Møller Nielsen, A Reimer, N Maxwell, K A Kubota, P Gerner-Smidt, MLVA Harmonization Working Group

Abstract readReview
In one paragraph

Review in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Molecular typing and seroepidemiology of pathogenicIranian journal of veterinary research · 2025
    Article
  5. Article
  6. Food science & nutrition · 2022
    Review
  7. Validation of a multilocus genotyping scheme for subtypingFood and waterborne parasitology · 2022
    Article
  8. Article
  9. Article
  10. Molecular characterization ofJournal of medical microbiology · 2021
    Article
  11. Article
  12. Subtyping β-lactamase-producingIranian journal of basic medical sciences · 2021
    Article
  13. Article
  14. An UnusualFrontiers in microbiology · 2020
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C A NadonNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
E Trees
L K Ng
E Møller Nielsen
A Reimer
N Maxwell
K A Kubota
P Gerner-Smidt
MLVA Harmonization Working Group

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Multiple-locus variable-number of tandem-repeats analysis (MLVA) has emerged as a valuable method for subtyping bacterial pathogens and has been adopted in many countries as a critical component of their laboratory-based surveillance. Lack of harmonisation and standardisation of the method, however, has made comparison of results generated in different laboratories difficult, if not impossible, and has therefore hampered its use in international surveillance. This paper proposes an international consensus on the development, validation, nomenclature and quality control for MLVA used for molecular surveillance and outbreak detection based on a review of the current state of knowledge.

Indexed as

Quality ControlClinical Laboratory TechniquesConsensusConsensus Statements as TopicDisease OutbreaksHumansInternational CooperationMultilocus Sequence TypingPopulation SurveillanceTandem Repeat Sequences

Identifiers

PMID24008231
PMCPMC5667538

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.